covid 19 News and Research

RSS

New UK supply contract for COVID-19 sample collection kits

EKF Diagnostics Holdings plc, the AIM listed point-of-care business, announces that it has received an initial order worth £3 m from a partner from the private sector to supply PrimeStore MTM, a novel patented sample collection device, to be used in a COVID-19 testing programme for UK staff.

From EKF Diagnostics 5 Aug 2020

Launching a rapid test for COVID-19

Professor Zhanfeng Cui from the University of Oxford speaks to News-Medical about his research into COVID-19, and how he developed a rapid COVID-19 test.

5 Aug 2020

Study shows higher COVID-19 rates among minority and socioeconomically disadvantaged children

Minority and socioeconomically disadvantaged children have significantly higher rates of COVID-19 infection, a new study led by Children's National Hospital researchers shows.

5 Aug 2020

Could labs that test livestock ease covid testing backlog for people? Well … maybe.

In a heated exchange late last month on CNN's State of the Union, host Jake Tapper pressed Adm. Brett Giroir, the Health and Human Services assistant secretary who oversees COVID testing efforts for the Trump administration, on why the government isn't requiring commercial labs to increase testing capacity in order to speed turnaround time.

5 Aug 2020

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

A laboratory test that has now been developed by a study group from MedUni Vienna is able to determine whether COVID-19 patients develop protective antibodies after having the disease.

5 Aug 2020

Pandemic’s bumps and backlash shape Montana race poised to steer US Senate

Bradshaw Sumners watched throughout February as COVID-19 hot spots developed in major American cities, waiting to see when the coronavirus pandemic would manifest in Montana.

5 Aug 2020

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

In a new study published on the preprint server bioRxiv researchers characterized the crystal structure of the antibody-SARS-CoV-2 RBD complex in an attempt to find the epitope and the mechanism that enables cross-neutralization.

5 Aug 2020

Large proportion of UK healthcare workers may have already had Covid-19 infection

A large proportion of UK healthcare workers may already have been infected with Covid-19, according to new research led by the University of East Anglia in collaboration with University College London.

5 Aug 2020

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Yellow fever, an acute viral hemorrhagic disease transmitted by infected mosquitoes, infects about 200,000 people and causes an estimated 30,000 deaths each year.

5 Aug 2020

Study: Many states lack flexible election policies to support safety measures during pandemic

Many states continue to lack the policies and preparations needed to address safety concerns of holding elections in November, despite the lessons learned in recent 2020 primary elections that were disrupted by the coronavirus pandemic, according to new research from the RAND Corporation.

5 Aug 2020

Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients

Neutrolis, a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cells in the body, today announced the development of NTR-441, a first-in-class DNASE1L3 enzyme analog that has the potential to rapidly and systemically clear neutrophil extracellular traps for severe cases of COVID-19.

5 Aug 2020

Embryos are susceptible to COVID-19 if mothers get sick, indicates study

Genes that are thought to play a role in how the SARS-CoV-2 virus infects our cells have been found to be active in embryos as early as during the second week of pregnancy, say scientists at the University of Cambridge and the California Institute of Technology (Caltech).

5 Aug 2020

Pediatric experts outline back-to-school safety guidelines for solid organ transplant recipients

As school districts look ahead to a very different school year, pediatric infectious disease experts from across the United States convened to outline back-to-school safety guidelines for solid organ transplant (SOT) recipients.

5 Aug 2020

Study shows link between selenium-deficient diet and paracetamol toxicity

A lack of the mineral selenium in the diet puts people at risk of paracetamol overdose, even when the painkiller is taken at levels claimed to be safe on the packaging, according to collaborative research emerging from the University of Bath and Southwest University in China.

5 Aug 2020

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Now, Regeneron Pharmaceuticals says its COVID-19 antibody-drug cocktail under development prevented and treated the disease in monkeys and hamsters, showing promise that it may work in humans.

5 Aug 2020

SNIS 17th Annual Meeting highlights COVID-19 and racial disparities in stroke treatment

The next frontier in neurointerventional surgery, including advances in stroke triage and management, innovations in artificial intelligence and robotics in endovascular surgery, new findings on racial disparities in stroke treatment and the neurologic impact of COVID-19 are a few of the topics that will be covered at the Society of NeuroInterventional Surgery's (SNIS) 17th Annual Meeting taking place virtually August 4-7, 2020.

5 Aug 2020

Study: "Memory" T cells that recognize common cold coronaviruses also recognize SARS-CoV-2

Your immune system's "memory" T cells keep track of the viruses they have seen before. This immune cell memory gives the cells a headstart in recognizing and fighting off repeat invaders.

5 Aug 2020

De novo protein decoys that block SARS-CoV-2

Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.

5 Aug 2020

Interleukin-6 inhibitors appear to be a more effective treatment for COVID-19

New research from Boston Medical Center found that patients experiencing severe COVID-19 symptoms had improved outcomes when administered an Interleukin-6 (IL6ri) inhibitor, sarilumab or tocilizumab, given to mediate severe systemic inflammatory responses.

5 Aug 2020

Dire COVID-19 warning from World Health Organization

The coronavirus pandemic (COVID-19) has swept across the globe, infecting more than 18 million people. With the rapid spread of the virus, the World Health Organization (WHO) warns that there might never be a “silver bullet” to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

5 Aug 2020

covid 19 News and Research

New UK supply contract for COVID-19 sample collection kits

Launching a rapid test for COVID-19

Study shows higher COVID-19 rates among minority and socioeconomically disadvantaged children

Could labs that test livestock ease covid testing backlog for people? Well … maybe.

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

Pandemic’s bumps and backlash shape Montana race poised to steer US Senate

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

Large proportion of UK healthcare workers may have already had Covid-19 infection

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Study: Many states lack flexible election policies to support safety measures during pandemic

Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients

Embryos are susceptible to COVID-19 if mothers get sick, indicates study

Pediatric experts outline back-to-school safety guidelines for solid organ transplant recipients

Study shows link between selenium-deficient diet and paracetamol toxicity

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

SNIS 17th Annual Meeting highlights COVID-19 and racial disparities in stroke treatment

Study: "Memory" T cells that recognize common cold coronaviruses also recognize SARS-CoV-2

De novo protein decoys that block SARS-CoV-2

Interleukin-6 inhibitors appear to be a more effective treatment for COVID-19

Dire COVID-19 warning from World Health Organization

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News